The Apollo Hospitals Group is a pioneer of integrated healthcare system in India. The hospital chain is led by its chairman Dr. Pratap Reddy. Apollo Hospitals Group, has Hospitals, Diagnostic Clinics, Pharmaceutical outlets and consultancy services. In addition, the group is involved in medical business process outsourcing, Telemedicine services, education, training programs, third party administration services and health insurance. The company has Fourteen subsidiary companies under its arms.Starting from a 150-bedded Hospital in 1983the group has grown well to have over 8500 beds across 50 hospitals at various locations in India and overseas it has over 4000 clinicians and total employee strength of more than 65,000 The Apollo Hospitals Group has added hospitals at important locations like Ahmedabad, Bangalore, Bilaspur, Mysore, Kolkatta, and Kakinada. It also has hospitals at Dubai, Saudi Arabia and Ghana. It is claimed that the hospital group has served over 26 million patients from 120 countries
To speak about the news related to this particular share, it touched its 52-week high Rs 902.85 on 27th November,2012 and 52-week low Rs 555 on 06 March, 2012. In February 28th there was a sale of 5,400,000 shares at Rs 824.55 on the BSE by HSTN Acquisition (FII) Ltd. Interestingly Oppenheimer Funds INC bought 4,900,000 shares at Rs 824.55.This group has seen a income growth of 20% The company’s dividend record is impressive. The last declared dividend was 80% of the face value . The face value of the share is Rs.5 while the Book value is at 191.54. Market capitalization is 11,091.75 Cr. The EPS (TTM) is 15.27 The P/E is 52.05 The company has received a AA rating from indicating CRISIL an indication of high safety. The company’s fundamentals also look good.
For long term investors with a long time frame this stock becomes suitable. Even for medium term investment this stock can give a satisfactory return. At the time of writing this review, the stock is trading at 797.15. the stock can be bought at these levels or accumulated. A medium term target of 934 looks achievable.
Disclaimer: The views expressed herein are based on openly available data collected. Before taking any investment decisions please consult your investment advisers. I do not have any interest in the company mentioned above.
